• ACTG Starts New weight Gain, HIV Study Including Switch to Doravirine - (07/30/21)
   
  
• Exposure to dolutegravir from two formulations in children in the ODYSSEY trial - Intl Pediatrics Workshop - (07/26/21)
   
  
• Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial - Intl Pediatrics Workshop - (07/26/21)
   
  
• Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review - Intl Pediatrics Workshop - (07/26/21)
   
  
• Virological failures and genotypic resistance in children and adolescents randomised to dolutegravir-based ART vs. standard-of-care in the ODYSSEY trial - Intl Pediatics Workshop - (07/26/21)
   
  
• DOLUTEGRAVIR-BASED ART IS SUPERIOR TO STANDARD OF CARE IN YOUNG CHILDREN LIVING WITH HIV - Intl Pediatrics Workshop - (07/26/21)
   
  
• ART & Cervical Cancer Women with HIV Risk - (07/26/21)
   
  
• IAS: Immunoscenescence and HIV: mutual interactions? - (07/26/21)
   
  
• IAS: Poor sleep quality in people with HIV linked to lower CSF amyloid beta 42 - (07/26/21)
   
  
• IAS: HCV Reinfection Rate Almost 4% in Global Analysis of People With HIV - Mark Mascolini (07/26/21)
   
  
More HIV Articles...
 

More News Updates Articles...
 

• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• EASL: Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges. Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany - (07/25/21)
   
  
• EASL: Persistent long-term risk of liver related complications in HCV patients after antiviral therapy - Data from the German Hepatitis C-Registry - (07/26/21)
   
  
• IAS: Drug Injecting Remains Barrier to HCV Elimination in Netherlands - Mark Mascolini (07/26/21)
   
  
• IAS: HCV Cure Rate 92% in Hard-to-Reach Vietnam Drug-Injecting Group - Mark Mascolini (07/26/21)
   
  
More Hep C Articles...
 

• EASL: Free-immunoglobulin alternative strategy to prevent HBV mother-to-child transmission in Cambodia: the ANRS 12345 TA-PROHM study - (07/10/21)
   
  
• EASL: Current or Past HBV Not Tied to Death With COVID in Hong Kong - Mark Mascolini (07/10/21)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.